Leadership Transition

Blue Zones Names Ex-Baptist Health CEO Brett McClung as New CEO

Image
Blue Zones Names Ex-Baptist Health CEO Brett McClung as New CEO

Minneapolis – October 05, 2026 -- Blue Zones has appointed Brett McClung as Chief Executive Officer and President, tapping a healthcare executive with more than two decades of experience to lead the longevity research company's next growth phase.

McClung brings direct Blue Zones Project implementation experience from two major health systems

McClung most recently served as President and CEO of Baptist Health in Jacksonville, Florida, where he championed bringing Blue Zones Project to the city. Before that, he was Executive Vice President and Chief Operating Leader of Texas Health Resources, serving as executive sponsor of Blue Zones Project in Fort Worth.

Asurion Names Baris Oran CFO, Succeeding 17-Year Veteran Magyera

Image
Asurion Names Baris Oran CFO, Succeeding 17-Year Veteran Magyera

Nashville -- Asurion has appointed Baris Oran as Chief Financial Officer, effective October 05, 2026, tapping a 25-year finance veteran to lead capital strategy at the global technology protection and support company.

Oran joins Asurion's Executive Committee reporting directly to CEO Guru Gowrappan

Oran most recently served as CFO of Amrize and spent nearly five years as CFO of GXO Logistics, where he built the finance organization following its spin-off from XPO Logistics. He previously held CFO roles at Sabancı Group and Kordsa, with experience spanning capital allocation, M&A and capital markets across technology, logistics and manufacturing sectors.

Fusion Connect Names Brian McClintock Permanent CEO

Image
Fusion Connect Names Brian McClintock Permanent CEO

Atlanta – – October 05, 2026 -- Fusion Connect's Board of Directors has appointed Brian McClintock as Chief Executive Officer and a board member, effective immediately, ending his tenure as Interim CEO that began in August 2026.

McClintock moves from CFO to permanent chief executive

McClintock previously served three years as Fusion Connect's Chief Financial Officer before stepping into the interim CEO role. He brings more than two decades of executive experience from Fusion Connect, Impact Telecom, KDDI Global and New Global Telecom, spanning finance, operations and organizational transformation.

Entergy Texas Names David Borde President and CEO

Image
Entergy Texas Names David Borde President and CEO

New Orleans – October 05, 2026 -- Entergy Texas has appointed David Borde as president and CEO, effective Oct. 5, succeeding Eliecer Viamontes, who has left the company for other opportunities.

Borde Steps Up From Regulatory Strategy Role

Borde most recently served as vice president of utility strategy and regulatory initiatives at Entergy, where he supported regulatory and tariff filings across the company's operating companies. He joined Entergy in 2009 as director of corporate development in Texas and later held roles including vice president of investor relations and positions within the utility finance business partner organization.

Smithsonian's Kirk Johnson to Lead Denver Museum of Nature & Science

Image
Smithsonian's Kirk Johnson to Lead Denver Museum of Nature & Science

Denver – October 02, 2026 -- The Denver Museum of Nature & Science Board of Trustees has named Kirk Johnson, Sant Director of the Smithsonian's National Museum of Natural History since 2012, as its next president and CEO, effective Feb. 1, 2027.

Johnson departs a museum holding 149 million specimens and drawing 4 million annual visitors

At the Smithsonian, Johnson has overseen the world's largest natural history collection and one of the institution's most visited sites. His tenure included the opening of the David H. Koch Hall of Fossils – Deep Time, a flagship exhibition tying Earth's biological history to contemporary issues.

Taejoon Ahn Named CEO of Washington Permanente Medical Group

Image
Taejoon Ahn Named CEO of Washington Permanente Medical Group

Seattle – October 01, 2026 -- Washington Permanente Medical Group (WPMG) has named Taejoon Ahn, MD, MPH, as its new CEO and executive medical director, placing him at the head of an organization that oversees more than 1,200 clinicians serving over 550,000 Kaiser Permanente members across Washington state.

Ahn succeeds interim leader Dorian Reid, who held the role since September 2025

Dr. Ahn takes over an independent, physician-owned medical group that works exclusively with Kaiser Permanente to deliver care in the region. The leadership transition closes a one-year interim period under Dorian Reid, MD.

Activation Capital Names Paul Nolde Chair, Ending Rao's 17-Year Tenure

Image
Activation Capital Names Paul Nolde Chair, Ending Rao's 17-Year Tenure

Richmond, Va. – September 30, 2026 -- Activation Capital, the operating name of the Virginia Biotechnology Research Partnership Authority, has elected Paul Nolde as chair of its Authority Board, succeeding Virginia Commonwealth University President Michael Rao, Ph.D., who held the role since 2009. Rao will remain an active board member.

Nolde takes over after serving as vice chair since January 2025

Nolde is President and CEO of 757 Collab and Executive Director of 757 Angels, a venture platform funding high-growth startups in Hampton Roads and across Virginia from post-ideation through seed stage. He previously served as Executive Managing Director of Richmond-based accelerator Lighthouse Labs, Fund Manager and Managing Director of Riverflow Growth Fund, a healthcare-focused seed fund, and as a director at early-stage venture firm NRV.

PhRMA Names Eric Cantor as Next President and CEO, Effective Nov. 9

Image
PhRMA Names Eric Cantor as Next President and CEO, Effective Nov. 9

Washington – September 29, 2026 -- The Pharmaceutical Research and Manufacturers of America (PhRMA) has named former House Majority Leader Eric Cantor as its next president and chief executive officer, effective November 9. Cantor succeeds Stephen J. Ubl, who has led the trade group since 2015 and will remain as a strategic advisor through January 15, 2027.

Amcor Names Tom Long Chairman as Liebelt Retires After 13 Years

Image
Amcor Names Tom Long Chairman as Liebelt Retires After 13 Years

Zurich – September 29, 2026 -- Amcor (NYSE: AMCR, ASX: AMC) confirmed that Graeme Liebelt will step down as Chairman after nearly 13 years, with the Board electing Tom Long as his successor effective at the company's Nov. 11, 2026 annual meeting.

Liebelt exits after leading Amcor through major portfolio transformation

Liebelt will not stand for re-election and will retire from Amcor's Board of Directors at the close of his current term. He chaired Amcor plc and its predecessor entity for nearly 13 years, overseeing expansion of the company's product portfolio and sustainability capabilities.

Tom Long brings CEO track record from MillerCoors and Miller Brewing

Long has served as an independent non-executive director on Amcor's Board since 2017. He was previously Chief Executive Officer of MillerCoors, LLC, and led Miller Brewing Company before its 2008 merger with Coors. Long currently chairs the Board of Wolverine Worldwide, Inc.

L2 Brands Names John Fryer CEO to Drive Next Growth Phase

Image
L2 Brands Names John Fryer CEO to Drive Next Growth Phase

Hanover, Pa. – September 29, 2026 -- L2 Brands, a premium custom-decorated apparel and headwear maker, appointed John Fryer as Chief Executive Officer effective September 29, 2026, tasking him with leading the company's fully integrated commercial, product, supply chain and manufacturing operations.

Fryer arrives from Unrivaled Teamwear's Hanesbrands carve-out

Fryer most recently served as President of Unrivaled Teamwear, a carve-out from Hanesbrands that operates the Champion Teamwear, Gear for Sports and Knights Apparel brands. His background spans activewear, teamwear and collegiate-channel businesses.